5 USPTO and 5 foreign PCT patents applications have been submitted and are under consideration in the United Sates (USPTO), Europe (EPO), Canada, Hong Kong and Mexico
A growing number of derivative applications are under development based on the initial divisions of the 5 USPTO and 5 PCT applications
Beginning with USPTO applications, Signe BioPharma Inc will seek propriety control of a four level plant based technology to produce specific functional human therapeutic proteins in amounts appropriate to their medical or commercial uses
The intellectual property (IP) of Signe BioPharma was developed by the Founder during tenure as a Professor of Biochemistry and Molecular Biology at the University of Texas Health Science Center at Houston, Texas.
All ownership rights to the 5 USPTO and 5 PCT patent applications, and any derivative applications, have been purchased outright from The University of Texas System and are now the exclusive and unencumbered property of Signe BioPharma Inc
USA Intellectual Property Law Firm - Winstead PC, Houston, Texas
IP Law Foreign Associates - Marks & Clerk (UK, EPO and Hong Kong), Deeth Williams Wall (Canada) and Panamericana de Patentes y Marcas (Mexico)